Search
for

    Sort by

    Research 91–120 of 203

    1. 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis International Braz J Urol · 2018 · 4 citations
    2. Serenoa Repens (Saw Palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part III Uro · 2021 · 3 citations
    3. 5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence Bladder cancer · 2020 · 3 citations
    4. Association Between 5-Alpha Reductase Inhibitor Use and The Risk of Depression: A Meta-Analysis. Urology Journal · 2020 · 3 citations
    5. Complications of cataract surgery in Wistar rats undergoing treatment with tamsulosin Experimental and Therapeutic Medicine · 2018 · 3 citations
    6. Steroid Hormones Elsevier eBooks · 2016 · 3 citations
    7. Clinical use of 5α-reductase inhibitors Cambridge University Press eBooks · 2001 · 3 citations
    8. Targeting a fibrotic bottleneck may provide an opening in the treatment of LUTS 2019 · 2 citations
    9. Effects of 5-alpha reductase inhibitors Current Opinion in Urology · 2018 · 2 citations
    10. Re: Risk of Erectile Dysfunction Associated with Use of 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia or Alopecia: Population Based Studies Using the Clinical Practice Research Datalink European Urology · 2017 · 2 citations
    11. Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review Annals of Dermatology · 2017 · 2 citations
    12. Dutasteride: A Review of its Use in the Management of Prostate Disorders Clinical medicine insights · 2011 · 2 citations
    13. Ether: Fiction or Reality? A Review Biomedical Journal of Scientific & Technical Research · 2025 · 1 citations
    14. Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review Curēus · 2023 · 1 citations
    15. Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia Clinical Breast Cancer · 2019 · 1 citations
    16. Re: Can Long-Term LUTS/BPH Pharmacological Treatment Alter the Outcomes of Surgical Intervention? The Journal of Urology · 2017 · 1 citations
    17. British Hair and Nail Society British Journal of Dermatology · 2016 · 1 citations
    18. The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being Current Sexual Health Reports · 2015 · 1 citations
    19. Clinical Pearls in Men's Health Mayo Clinic Proceedings · 2010 · 1 citations
    20. Effect of the ethanol extract of Syzygium aromaticum (clove) leaves on the lipid profile and body weight in testosterone-induced benign prostatic hyperplasia rats Global Translational Medicine · 2026
    21. Human pluripotent stem cell-derived skin organoids enabled pathophysiological model of Mycobacterium tuberculosis infection Nature Communications · 2025
    22. Scientific augmentation of BPH and its treatment in Unani medicine the review Journal of Drug Delivery and Therapeutics · 2025
    23. Effects of local and systemic medications on eye health: Adverse reactions Hospital Pharmacology - International Multidisciplinary Journal · 2025
    24. Evaluación de la seguridad de minoxidil oral a dosis bajas en el tratamiento de la alopecia e_Buah · 2024
    25. Chemically Induced Hair Loss/Alopecia Springer eBooks · 2019
    26. Re: Long-Term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial The Journal of Urology · 2017
    27. Konvergentna validacija farmakoekonomskih aspekata terapije benigne hiperplazije prostate u Crnoj Gori National Repository of Dissertations in Serbia · 2016
    28. Finasteride en el año 2006 Revista Argentina de Urología · 2006
    29. Clinical results with finasteride. PubMed · 1994 · 2 citations
    30. 69-Year-Old Man With Nasal Congestion and Pre-Syncope Mayo Clinic Proceedings · 2021 · 1 citations